The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of copper-depletion using tetrathiomolybdate (TM) in patients (pts) with breast cancer (BC) at high risk for recurrence: Updated results.
 
Sheena Sahota
No Relationships to Disclose
 
Naomi Kornhauser
No Relationships to Disclose
 
Amy Willis
No Relationships to Disclose
 
Maureen M. Ward
No Relationships to Disclose
 
Tessa Cigler
Honoraria - Novartis
Speakers' Bureau - Novartis
 
Anne Moore
No Relationships to Disclose
 
Eleni Andreopoulou
No Relationships to Disclose
 
Veronica Fitzpatrick
No Relationships to Disclose
 
Sarah E. Schneider
No Relationships to Disclose
 
Alysia Wiener
No Relationships to Disclose
 
Anna Rubinchik
No Relationships to Disclose
 
Sharrell Lee
No Relationships to Disclose
 
Maureen E. Lane
No Relationships to Disclose
 
Vivek Mittal
No Relationships to Disclose
 
Linda T. Vahdat
Consulting or Advisory Role - Berg Pharma
Speakers' Bureau - Eisai
Research Funding - Abbvie (Inst); AstraZeneca (Inst); celldex (Inst); Clovis Oncology (Inst); Galena Biopharma (Inst); Immunomedics (Inst); millennium (Inst); Optimer Biotechnology (Inst); PharmaMar (Inst); Polyphor (Inst)
Patents, Royalties, Other Intellectual Property - we have a patent pending on the application for BMD progenitor cells (Inst)